Pledge Tx

Foundation date



#Biotechnology - Therapeutics


Therapeutic areas

Pledge Therapeutics discovers and develops small molecule drugs that demonstrate target engagement and therefore deliver durable disease-modifying effect. Our goal is to bring drug candidates with novel mechanisms of action to a stage more suitable for strategic co-development.

Upcoming events

Latest news

  • Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    17 hours ago

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023